Literature DB >> 23891054

Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP.

Andrew J Pugely1, John J Callaghan, Christopher T Martin, Peter Cram, Yubo Gao.   

Abstract

Recently, the government has moved towards public reporting of 30-day readmission rates after elective primary total knee (TKA) and total hip arthroplasty (THA). We identified 11,814 and 8105 patients who underwent primary TKA and THA from the 2011 ACS NSQIP. Overall readmission rates within 30-days of surgery were 4.6% for TKA and 4.2% for THA. Complications associated with readmission were predominantly wound infections, sepsis, thromboembolic, cardiac, and respiratory related. In TKA, multivariate analysis identified age (P=0.002), male gender (P=0.03), cancer history (P=0.008), elevated BUN (P=0.002), a bleeding disorder (P<0.001) and high ASA class (P<0.001) as predictors of readmission. In THA, obesity (P=0.008), steroid use (P=0.037), a bleeding disorder (P=0.002), dependent functional status (P=0.022), and high ASA class (P<0.001) predicted readmission. Understanding characteristics associated with readmission will be essential for equitable patient risk stratification.
© 2013.

Entities:  

Keywords:  30-day; NSQIP; THA; TKA; arthroplasty; readmission; risk factors

Mesh:

Year:  2013        PMID: 23891054     DOI: 10.1016/j.arth.2013.06.032

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  64 in total

1.  Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique.

Authors:  Wade Gofton; James Chow; K Dean Olsen; David A Fitch
Journal:  Int Orthop       Date:  2014-11-16       Impact factor: 3.075

2.  Association of Pain on Hospital Discharge with the Risk of 30-Day Readmission in Patients with Total Hip and Knee Replacement.

Authors:  Ickpyo Hong; Jordan R Westra; James S Goodwin; Amol Karmarkar; Yong-Fang Kuo; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2020-07-03       Impact factor: 4.757

3.  Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Authors:  Elizabeth W Paxton; Maria C S Inacio; Jasvinder A Singh; Rebecca Love; Stefano A Bini; Robert S Namba
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

4.  CORR Insights®: Are Readmissions After THA Preventable?

Authors:  Rajiv Gandhi
Journal:  Clin Orthop Relat Res       Date:  2017-02-24       Impact factor: 4.176

Review 5.  Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach.

Authors:  Benedict Morath; Tanja Mayer; Alexander Francesco Josef Send; Torsten Hoppe-Tichy; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Br J Clin Pharmacol       Date:  2017-06-14       Impact factor: 4.335

6.  Are Readmissions After THA Preventable?

Authors:  Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera
Journal:  Clin Orthop Relat Res       Date:  2016-11-11       Impact factor: 4.176

7.  Predictors of hospital readmission following revision total knee arthroplasty.

Authors:  Philip J Belmont; Gens P Goodman; Marina Rodriguez; Julia O Bader; Brian R Waterman; Andrew J Schoenfeld
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-09-19       Impact factor: 4.342

8.  Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Brent J Morris; David Mannino; Andrew Hoellein; Ryan P Donegan; Leslie J Crofford
Journal:  Semin Arthritis Rheum       Date:  2016-08-24       Impact factor: 5.532

9.  Incidence And Risk Factors For 30-Day Readmissions After Hip Fracture Surgery.

Authors:  Christopher T Martin; Yubo Gao; Andrew J Pugely
Journal:  Iowa Orthop J       Date:  2016

10.  Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma.

Authors:  Javier Valero-Elizondo; Yuhree Kim; Jason D Prescott; Georgios A Margonis; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.